KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 9 analysts with an average price target of $336.11. This is a potential upside of $44.16 (-0.17%) from yesterday's end of day stock price of $336.67.

Krystal Biotech's activity chart (see below) currently has 148 price targets and 130 ratings on display. The stock rating distribution of KRYS is 92% BUY and 8% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 98.21% with an average time for these price targets to be met of 223 days.

Highest price target for KRYS is $403, Lowest price target is $217, average price target is $336.11.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 04-Aug-2026. First documented stock forecast 18-Oct-2017.

Best performing analysts who are covering KRYS - Krystal Biotech:

Roger Song Geulah Livshits Andrea Tan Yigal Nochomovitz Joshua Schimmer

Currently out of the existing stock ratings of KRYS, 23 are a BUY (92%), 2 are a HOLD (8%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Jan-2026

$386

$39 (11.24%)

$378

1 months 13 days ago
(04-Aug-2026)

10/11 (90.91%)

$61.23 (18.85%)

178

Buy Since 19-Jan-2022

$396

$49 (14.12%)

$318

2 months 3 days ago
(14-Jul-2026)

8/9 (88.89%)

$56.57 (16.67%)

183

Buy Since 29-Nov-2021

$403

$30.75 (8.26%)

$306

2 months 30 days ago
(18-Jun-2026)

9/10 (90%)

$54.94 (15.78%)

254

Buy Since 24-Sep-2018

$361

$-11.25 (-3.02%)

$310

3 months 1 days ago
(16-Jun-2026)

46/46 (100%)

$37.63 (11.64%)

207

Buy Since 29-Mar-2022

$284

$-88.25 (-23.71%)

$189

6 months 23 days ago
(25-Feb-2026)

6/6 (100%)

$11.5 (4.22%)

128

Show more analysts

Please expand the browser size to see the chart

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 223 days for the stock forecasts to be reached, with an average price target met ratio of 98.21%.

Which analyst most recently updated their price target on KRYS (Krystal Biotech)?

Yigal Nochomovitz

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Yigal Nochomovitz works at CITI and has 3 price targets and 2 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Ritu Baral with the highest potential upside of $56

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with the lowest potential downside of -$209

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?